Indeed, although an increase in apoptosis-related proteins has been observed in reaction to AdipoRon administration in PDAC, myeloma and ovarian cancer, programmed cell death does not appear to be the only signaling engaged in AdipoRon-mediated toxicity and, moreover, contrasting evidence also exists regarding the apoptosis involvement, especially in PDAC [52,53,54]. The gene discussed is FAM215A; the disease is ovarian carcinoma.